Bill An­der­son to step down as Roche phar­ma chief by mon­th's end

Roche will see some more change atop its ranks as Bill An­der­son, the head of its phar­ma­ceu­ti­cals group, will step down at the end of the year.

An­der­son is step­ping down on Dec. 31 to “pur­sue op­por­tu­ni­ties out­side of Roche,” the Big Phar­ma an­nounced ear­ly Mon­day morn­ing. His suc­ces­sor will be ap­point­ed by March of next year, Roche added.

The move comes af­ter Roche CEO Sev­erin Schwan an­nounced ear­li­er this year that he’d be pass­ing the ba­ton to Thomas Schi­neck­er, for­mer­ly head of Roche’s di­ag­nos­tics group. Schi­neck­er will al­so fill in as in­ter­im phar­ma­ceu­ti­cals chief un­til the com­pa­ny finds a full-time ap­point­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER